Cell model | Nanoparticles | Drug loading | ROS scavenging | Targeting strategies | Results | Refs. | |
---|---|---|---|---|---|---|---|
RAW 264.7 HUVECs | LFP/PCDPD | Pred | Clear ROS | Active targeting (VCAM-1, CD44) | Anti-inflammatory, lipid removal, fluorescent imaging | [102] | Â |
RAW 264.7 | PLCDP@PMH | Pred | Clear ROS | Active targeting (VCAM-1, CD44) | Lipid modulation, inhibition of macrophage polarization to M1 type, plaque diagnosis | [103] | Â |
RAW 264.7 LO2 | HA/HPEMs | SIM | Clear ROS | Active targeting (CD44) | Anti-inflammatory, antioxidant, inhibits macrophage growth | [104] | Â |
RAW 264.7 | RBC/LFP@PMMP | Pred | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, and lipid imaging | [105] | Â |
RAW 264.7 HUVECs | SV MC@RBCs | SIM | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, antithrombotic, shear stress responsive | [106] | Â |
RAW 264.7 ECs | RP-PU | PB | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, hypolipidemic, inhibits foam cell formation | [107] | Â |
RAW 264.7 HUVECs | KPF@MM-NPs | KPF | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, promotes macrophage polarization from M2 to M1 type and enhances internalization | [108] | Â |
RAW 264.7 HUVECs | SA PAM@RBCs | SIM | Clear ROS | Passive targeting | Antioxidant reduces plaque count, shear stress responsive | [109] | Â |
RAW 264.7 | TPP@PMM | Pred | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, inflammatory diagnosis | [110] | Â |
RAW 264.7 LO2 | TPTS/C/T | SIM | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, inhibits macrophage polarization to M1 type, synergistic therapy | [111] | Â |
RAW 264.7 HUVECs | SE-LNPs | SIM | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant, anti-apoptotic, hypolipidemic, promotes macrophage polarization to M2 type | [112] | Â |
RAW 264.7 | PEG-PPS | Andro | Clear ROS | Passive targeting | Anti-inflammatory, antioxidant | [113] | Â |